Age‑Specific Thyroid Hormone Reference Ranges and Management in Children

Interpretation of Pediatric Thyroid Reference Ranges

Age‑dependent reference ranges for TSH, free T4, and free T3 differ markedly from adult values, so clinicians must use pediatric‑specific limits to avoid misdiagnosis of thyroid disorders. 1

Blood for thyroid function testing should be drawn ≥ 4 hours after levothyroxine administration to prevent transient suppression of TSH that could lead to inaccurate interpretation. 1

Immediate levothyroxine therapy is indicated when a newborn’s venous free T4 falls below the age‑specific lower limit. 1
Treatment should also begin when venous TSH ≥ 20 mIU/L, even if free T4 is within normal limits, to prevent neurodevelopmental impairment. 1
For infants ≥ 21 days old with TSH 6–20 mIU/L and normal free T4, clinicians should obtain thyroid imaging and either start treatment promptly with later reassessment or closely monitor with repeat testing in 2 weeks. 1

Maintain TSH within the age‑specific reference interval, avoiding excessively low values (< 0.05 mIU/L) that may indicate overtreatment. Evidence from two studies supports this target. [1][2]
Aim to keep free T4 in the upper half of the age‑specific reference range, especially during the first three years of life, to ensure optimal neurocognitive outcomes. Evidence from two studies supports this approach. [1][2]
Do not reduce levothyroxine dose based on a single isolated elevated free T4 measurement; repeat testing is required to confirm a true trend before adjusting therapy. 1

A comprehensive pediatric thyroid evaluation should include serum TSH, free T4, free T3, anti‑thyroid antibodies (anti‑TPO, anti‑thyroglobulin) when autoimmune disease is suspected, and TSH‑receptor antibodies when Graves’ disease is suspected. [3][4]

When monitoring levothyroxine therapy, blood samples must be drawn at least 4 hours after the dose to avoid transient suppression of TSH. 3

Applying adult reference ranges to children leads to misdiagnosis, frequently missing mild subclinical hypothyroidism or falsely labeling hyperthyroidism. 3
In children with suppressed TSH, free T3 should be measured; failure to do so can miss T3‑predominant hyperthyroidism, which occurs in roughly 13 % of pediatric hyperthyroid patients, especially younger children. 4
Biotin supplementation interferes with streptavidin‑biotin immunoassays and can produce false‑positive hyperthyroidism results. 5

Immediate treatment is indicated when venous free T4 falls below the age‑specific reference range. 3
Therapy should be started if venous TSH ≥ 20 mIU/L, even when free T4 is within normal limits. 3

Children 1–3 years old require thyroid function testing every 2–4 months during treatment. 3
After age 3 years and until growth completion, testing is recommended every 3–12 months, with more frequent checks if adherence is uncertain or abnormal values arise. 3